Omar Gonzalez
Baylor College of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Omar Gonzalez.
Clinical Infectious Diseases | 2003
Omar Gonzalez; Daniel M. Musher; Indira Brar; Seth Furgeson; Maha R. Boktour; Edward Septimus; Richard J. Hamill; Edward A. Graviss
Intravesical instillation of bacille Calmette-Guérin (BCG) effectively treats transitional cell carcinoma of the bladder. Occasionally, BCG infection complicates such treatment. In some patients, infection appears early (within 3 months after instillation) and is characterized by generalized symptoms, with pneumonitis and hepatitis. Late-presentation disease occurs >1 year after the first BCG treatment and usually involves focal infection of the genitourinary tract (the site at which bacteria were introduced) and/or other sites that are typical for reactivation of mycobacterial disease, such as the vertebral spine or the retroperitoneal tissues. Noncaseating granulomas are found in the majority of cases, whether early or late. Most patients respond to treatment with antituberculous drugs; in early-presentation disease, when features of hypersensitivity predominate, glucocorticosteroids are sometimes added. Late localized infection often requires surgical resection.
Stereotactic and Functional Neurosurgery | 2017
Tsinsue Chen; Zaman Mirzadeh; Margaret Lambert; Omar Gonzalez; Ana Moran; Andrew G. Shetter; Francisco A. Ponce
Background: Deep brain stimulation (DBS) hardware infection is a serious complication, often resulting in multiple hardware salvage attempts, hospitalizations, and long-term antibiotic therapy. Objectives: We aimed to quantify the costs of DBS hardware-related infections in patients undergoing eventual device explantation. Methods: Of 362 patients who underwent 530 electrode placements (1 January 2010 to 30 December 2014), 16 (4.4%) had at least 2 hardware salvage procedures. Most (n = 15 [93.8%]) required complete explantation due to recurrent infection. Financial data (itemized hospital and physician costs) were available for 13 patients and these were analyzed along with the demographic data. Results: Each patient underwent 1-5 salvage procedures (mean 2.5 ± 1.4; median 2). The mean total cost for a patient undergoing the median number of revisions (n = 2), device explantation, and subsequent reimplantation after infection clearance was USD 75,505; just over half this cost (54.2% [USD 40,960]) was attributable to reimplantation, and nearly one-third (28.9% [USD 21,816]) was attributable to hardware salvage procedures. Operating-room costs were the highest cost category for hardware revision and explantation. Medical and surgical supplies accounted for the highest reimplantation cost. Conclusions: DBS infection incurs significant health care costs associated with hardware salvage attempts, explantation, and reimplantation. The highest cost categories are operating-room services and medical and surgical supplies.
Journal of Neurosurgery | 2014
Douglas A. Hardesty; Wyatt Ramey; Mohammad Afrasiabi; Brian Beck; Omar Gonzalez; Ana Moran; Peter Nakaji
OBJECTIVES Coccidioidomycosis is a common fungal infection in the southwestern US. Hydrocephalus is a serious complication of cranial coccidioidomycosis, and the surgical management of coccidioidomycosis-related hydrocephalus has unique challenges. The authors reviewed their institutional experience with hydrocephalus in the setting of coccidioidomycosis. METHODS The authors retrospectively identified 44 patients diagnosed with coccidioidomycosis-related hydrocephalus at their institution since 1990, who underwent a total of 99 shunting procedures. The authors examined patient demographics, type of shunt and valve used, pressure settings, failure rates, medical treatment, ventricular response to shunting, and other variables. RESULTS The majority of patients were young (average age 37 years) men (male/female ratio 28:16) with a mean follow-up of 63 months. Patients of Asian and African descent were overrepresented in the cohort compared with regional demographic data. The overall shunt failure rate during follow-up was 50%, and the average number of revisions required if the shunt failed was 2.5 (range 1-8). Low to moderate draining pressures (mean 88 mm H2O) were used in this cohort. Fourteen patients received intrathecal antifungals, and a trend of initiating intrathecal therapy after need for a shunt revision was observed (p = 0.051). The majority of shunt failures (81%) were due to mechanical blockages in the drainage system. Most patients (59%) had at least partial persistent postoperative ventriculomegaly despite successful CSF diversion. Four patients (9%) died due to coccidioidomycosis during the follow-up period. CONCLUSIONS Coccidioidomycosis-related hydrocephalus more often affected young males in the studys cohort, especially those of African and Asian descent. Despite the best medical therapy, there was a high rate of shunt failure due to clogged catheters or valves due to the underlying disease process. Many patients continued to have ventriculomegaly even with adequate CSF diversion. The morbidity and mortality of this chronic disease process must be recognized by the treatment team, and patients should be appropriately counseled.
Open Forum Infectious Diseases | 2014
Ana Moran; Wyatt Ramey; Brian Beck; Yashar Kalani; Andrew Montoure; Kris A. Smith; Nicholas Theodore; Peter Nakaji; Omar Gonzalez
Meningitis: An Institutional Review Ana Moran, MD; Wyatt Ramey; Brian Beck MD; Yashar Kalani, MD, PhD; Andrew Montoure; Kris Smith; Nicholas Theodore, MD; Peter Nakaji, MD; Omar Gonzalez, MD; Infectious Diseases, Barrow Neurological Institute, Phoenix, AZ; Barrow Neurological Institute, Phoneix, AZ; Neurology, Barrow Neurological Institute, Phoenix, AZ; Neurosurgery, Barrow Neurological Institute, St. Joseph Hospital, Phoenix, AZ; Neurosurgery, Barrow Neurological Institute, Phoenix, AZ; Arizona Pulmonary Specialists, Phoenix, AZ
The Journal of Infectious Diseases | 2005
Imtiaz Yakub; Kristy M. Lillibridge; Ana Moran; Omar Gonzalez; John W. Belmont; Richard A. Gibbs; David J. Tweardy
International Journal of Tuberculosis and Lung Disease | 2003
Omar Gonzalez; Gerald J. Adams; Larry D. Teeter; T. T. Bui; James M. Musser; Edward A. Graviss
The Journal of Infectious Diseases | 2003
Xin Ma; Robert Reich; Omar Gonzalez; Xi Pan; Amanda K. Fothergill; Jeffery R. Starke; Larry D. Teeter; James M. Musser; Edward A. Graviss
International Journal of Tuberculosis and Lung Disease | 2003
Omar Gonzalez; Larry D. Teeter; B. T. Thanh; James M. Musser; Edward A. Graviss
Journal of Neurological and Neurosurgical Nursing | 2012
Virginia Pendergast; Ingalill Rahm Hallberg; Ulf Jakobsson; Stefan Renvert; Ana Moran; Omar Gonzalez
World Neurosurgery | 2017
Eduardo Martinez-del-Campo; Samuel Kalb; Leonardo Rangel-Castilla; Karam Moon; Ana Moran; Omar Gonzalez; Hector Soriano-Baron; Nicholas Theodore